UK health authorities yesterday announced a pioneering research program using the genomes of 100,000 newly born babies to detect rare genetic illnesses and speed up treatment.
The ￡105 million (US$129 million) publicly funded “Newborn Genomes Programme” — billed as the largest study of its kind in the world — would establish whether genomic sequencing to diagnose such conditions should be rolled out across the whole nation to ensure earlier interventions.
Some 200 conditions affecting a total of 3,000 newborn babies every year in the UK would be screened.
“We will only be looking at conditions that are treatable and early childhood conditions,” said Rich Scott, chief medical officer for Genomics England, which was set up by the health department in 2013.
They include biotinidase deficiency — a genetic disorder in which the body is unable to metabolize the vitamin biotin.
David Bick, clinical adviser to the program, said the condition, which can lead to seizures, severe skin rashes and neurological problems, can be prevented by over-the-counter vitamins.
“We don’t want to wait until they arise to treat them,” he added.
Scott said that as well as pinpointing conditions, the program, which is due to begin next year, would give an idea of public attitudes toward the lifetime storage of genomic data.
Potentially, the information could be used to help with an individual’s future healthcare needs “to predict to diagnose or to treat conditions, for example, if they fall sick later on,” he added.
The researchers intend to recruit from a broad spectrum of participants from different backgrounds, and in whom there is not necessarily an identified pre-existing risk.
“That crucially means that many of the parents we’re approaching won’t have any prior knowledge necessarily of genetics or inherited conditions in their family,” said Amanda Pichini, a genetics counselor at Genomics England.
If the trials prove successful, researchers aim to sequence the entire genome of newborns, alongside the existing heel-prick tests already carried out for nine rare but serious diseases in newborns, including sickle cell disease and cystic fibrosis.
British Secretary of State for Health and Social Care Steve Barclay said “the potential for genomics to revolutionize the way we deliver health care is great.”
“If we can detect treatable illnesses earlier and ensure patients access potentially lifesaving treatment faster, we could improve people’s lives across the country, including thousands of babies, through this new pilot,” he said in a statement.
His department highlighted the results of a public consultation, published in July last year, indicating support for the use of genome sequencing in newborns if strong safeguards are in place.
Two other research programs were also announced: one, with ￡22 million of government funding, is to sequence the genomes of up to 25,000 participants from non-European backgrounds, who are “currently underrepresented” in research.
It aims to better understand DNA and its “impact on health outcomes,” and to help “reduce health inequalities and level up patient outcomes across all communities,” the Department of Health and Social Care said.
The other, with initial funding of ￡26 million, focuses on the evaluation of sequencing to improve accuracy and speed in cancer diagnosis.
In total the government has announced ￡175 million in funding for genomics research.
The collapse of the Swiss Birch glacier serves as a chilling warning of the escalating dangers faced by communities worldwide living under the shadow of fragile ice, particularly in Asia, experts said. Footage of the collapse on Wednesday showed a huge cloud of ice and rubble hurtling down the mountainside into the hamlet of Blatten. Swiss Development Cooperation disaster risk reduction adviser Ali Neumann said that while the role of climate change in the case of Blatten “still needs to be investigated,” the wider impacts were clear on the cryosphere — the part of the world covered by frozen water. “Climate change and
Packed crowds in India celebrating their cricket team’s victory ended in a deadly stampede on Wednesday, with 11 mainly young fans crushed to death, the local state’s chief minister said. Joyous cricket fans had come out to celebrate and welcome home their heroes, Royal Challengers Bengaluru, after they beat Punjab Kings in a roller-coaster Indian Premier League (IPL) cricket final on Tuesday night. However, the euphoria of the vast crowds in the southern tech city of Bengaluru ended in disaster, with Indian Prime Minister Narendra calling it “absolutely heartrending.” Karnataka Chief Minister Siddaramaiah said most of the deceased are young, with 11 dead
Poland is set to hold a presidential runoff election today between two candidates offering starkly different visions for the country’s future. The winner would succeed Polish President Andrzej Duda, a conservative who is finishing his second and final term. The outcome would determine whether Poland embraces a nationalist populist trajectory or pivots more fully toward liberal, pro-European policies. An exit poll by Ipsos would be released when polls close today at 9pm local time, with a margin of error of plus or minus 2 percentage points. Final results are expected tomorrow. Whoever wins can be expected to either help or hinder the
DENIAL: Musk said that the ‘New York Times was lying their ass off,’ after it reported he used so much drugs that he developed bladder problems Elon Musk on Saturday denied a report that he used ketamine and other drugs extensively last year on the US presidential campaign trail. The New York Times on Friday reported that the billionaire adviser to US President Donald Trump used so much ketamine, a powerful anesthetic, that he developed bladder problems. The newspaper said the world’s richest person also took ecstasy and mushrooms, and traveled with a pill box last year, adding that it was not known whether Musk also took drugs while heading the so-called US Department of Government Efficiency (DOGE) after Trump took power in January. In a
RSS